- Q3 2023 Astria Therapeutics Inc Earnings Call TranscriptNov 13, 2023$4.49 (-2.39%)Earnings
- Astria Therapeutics Inc to Discuss the OX40 Program STAR-0310 Call TranscriptOct 12, 2023
- Astria Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q4 2022 Astria Therapeutics Inc Earnings Call TranscriptMar 22, 2023$11.33 (+0.98%)Earnings
- Astria Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Astria Therapeutics Inc Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 TranscriptDec 15, 2022
- Astria Therapeutics Inc at Jefferies London Healthcare Conference TranscriptNov 16, 2022
- Astria Therapeutics Inc R&D Day: Update On STAR-0215 And Its Clinical Development For The Prevention Of HAE Attacks TranscriptSep 30, 2022
- Q3 2021 Astria Therapeutics Inc Earnings Call TranscriptNov 10, 2021$7.07 (+0.86%)Earnings
- Catabasis Pharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 13, 2021
- Catabasis Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 02, 2021
- Catabasis Pharmaceuticals Inc Acquisition of Quellis Biosciences Inc Call TranscriptJan 29, 2021
- Catabasis Pharmaceuticals, Inc. - Special Call TranscriptSep 11, 2020
- Q4 2019 Catabasis Pharmaceuticals Inc Earnings Call TranscriptMar 10, 2020$28.74 (+1.91%)Earnings
- Q3 2019 Catabasis Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019$31.74 (+1.93%)Earnings
- Q2 2019 Catabasis Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2019$39.66 (+1.85%)Earnings
- Q1 2019 Catabasis Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2019$47.46 (+4.91%)Earnings
- Q4 2018 Catabasis Pharmaceuticals Inc Earnings Call TranscriptMar 14, 2019$34.8 (+3.57%)Earnings
Q3 2023 Astria Therapeutics Inc Earnings Call Transcript
Good morning. And welcome to the Astria Therapeutics quarter three 2023 corporate update. (Operator Instructions) As a reminder, this call is being recorded. And a replay will be made available on the Astria website following the conclusion of the event. I'd now like to turn the call over to Liz Higgins, Director of Communications and Investor Relations at Astria Therapeutics. Please go ahead, Liz.
Thank you, Tara. Welcome to today's Astria Therapeutics Q3 2023 conference call. With me today are Jill Milne, Chief Executive Officer; Christopher Morabito, Chief Medical Officer; Andrew Komjathy, Chief Commercial Officer; Andrea Matthews, Chief Business Officer; and Noah Clauser, Chief Financial Officer.
We issued a press release this morning summarizing our corporate update and third quarter financial results, which we will reference on today's call and is available on our website. We are also using slides during today's call that are available within the Events and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)